| Literature DB >> 29986035 |
Emily Speranza1,2,3,4, Paula Ruibal5, Julia R Port5,6, Feng Feng1,4, Lia Burkhardt7, Adam Grundhoff7, Stephan Günther5,6, Lisa Oestereich5,6, Julian A Hiscox8,9, John H Connor1,2,3,4, César Muñoz-Fontela5,6.
Abstract
Differences in T-cell phenotype, particularly the expression of markers of T-cell homeostasis, have been observed in fatal and nonfatal Ebola virus disease (EVD). However, the relationship between these markers with T-cell function and virus clearance during EVD is poorly understood. To gain biological insight into the role of T cells during EVD, combined transcriptomics and T-cell receptor sequencing was used to profile blood samples from fatal and nonfatal EVD patients from the recent West African EVD epidemic. Fatal EVD was characterized by strong T-cell activation and increased abundance of T-cell inhibitory molecules. However, the early T-cell response was oligoclonal and did not result in viral clearance. In contrast, survivors mounted highly diverse T-cell responses, maintained low levels of T-cell inhibitors, and cleared Ebola virus. Our findings highlight the importance of T-cell immunity in surviving EVD and strengthen the foundation for further research on targeting of the dendritic cell-T cell interface for postexposure immunotherapy.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29986035 PMCID: PMC7191875 DOI: 10.1093/infdis/jiy352
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226